Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases

Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases

Introduction: The clinical and therapeutic management of mixed cryoglobulinemia (MC) remains a subject of controversy. In addition, most studies have not recorded the long-term follow-up and the outcome of these cases. Material and Methods: We enrolled 246 patients affected by MC who were consecutiv...

Full description

Bibliographic Details
Main Authors: Cesare Mazzaro, Luigino Dal Maso, Endri Mauro, Valter Gattei, Michela Ghersetti, Pietro Bulian, Giulia Moratelli, Gabriele Grassi, Francesca Zorat, Gabriele Pozzato
Format: Article
Language:English
Published: MDPI AG 2018-05-01
Series:Diseases
Subjects:
hepatitis C virus
mixed cryoglobulinemia
interferon alpha
steroids
rituximab
Online Access:http://www.mdpi.com/2079-9721/6/2/35

Internet

http://www.mdpi.com/2079-9721/6/2/35

Similar Items